Feature

Noninvasive Assessment to Identify Patients With At-Risk Metabolic Dysfunction-Associated Steatohepatitis

Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease, is a major global health issue and a leading cause of chronic liver […]

Feature

Alcohol Use Disorder and Alcohol-Associated Liver Disease: New Definitions, Screening, and Treatment

Abstract: Alcohol-associated liver disease (ALD) poses a significant global health burden and is a leading cause of liver-related morbidity and mortality. ALD encompasses a spectrum of […]

Advances in IBS

Highlights From the Joint AGA/ACG Guideline on Pharmacologic Management of Chronic Idiopathic Constipation

G&H  What was the aim of the 2023 AGA/ACG guideline on chronic idiopathic constipation?  LC  The aim was to perform a systematic review and meta-analysis of […]

Advances in Hepatology

Management of Suboptimal Response in Primary Biliary Cholangitis Treatment

G&H  Currently, what are the main treatment goals for primary biliary cholangitis? GH  The goals of primary biliary cholangitis (PBC) treatment are evolving and becoming more […]

Advances in IBD

Early Surgery for Patients With Ileal Crohn’s Disease

G&H  Could you explain the concept of early surgery in ileal Crohn’s disease? GD  Surgery has traditionally been used for the treatment of medically intractable disease […]

Letter From the Editor

Letter From the Editor: Exploring Alcohol Use Disorder and Alcohol-Associated Liver Disease

Alcohol-associated liver disease (ALD) is one of the most common causes of liver-related morbidity and death globally. Consuming alcohol elevates the risk of ALD development and […]

CCF Resource Highlight: IBD Clinical Hub

https://crohnscolitisprofessional.org/